YvankaGilliam

Dr Yvanka Gilliam has over 25 years of clinical operations, medical affairs, health economics outcomes research (HEOR), digital health, commercial launch, and market access experience focusing on emerging markets within the Pharmaceutical, Biotechnology, and Diagnostic industries. She is the CEO and Founder of Clinical Research Advancement.

Dr Gilliam is the Director of Clinical Alliances for the Consortium for Clinical Research and Innovation, Singapore (CRIS), a subsidiary of the Ministry of Health (MOH) she is also on the Advisory board for MyCLNQ Health.

Dr Gilliam has served as the Vice President of Operations for Diaceutics within the Asia Pacific, Middle East and Africa regions. Before joining Diaceutics, she was the VP of Clinical Affairs and Real World Evidence (RWE) with Kantar Health. She has also served as the VP and Head of Real World Evidence at IQVIA based in Singapore.

Her early career focussed on the successful launch of novel Oncology compounds in the US, APAC, and LATAM regions where she collaborated on the successful launch of 9 novel Oncology compounds and a companion diagnostic. Dr Gilliam specialises in Thoracic and Hepatocellular Oncology, Women's Health and Diagnostics.

Dr Gilliam is passionate about the advancement of Clinical research initiatives that support health equity, improve patient outcomes, and result in the generation of real-world evidence. She is the Founder and CEO of Precision Health Providers Of

Louisiana, a Community clinic focussed on Health Equity and Inclusive Clinical research based in Shreveport, Louisiana, Hope for Louisiana Clinic Foundation and the Young Scientists Scholars Academy focussed on assisting young adults interested in exploring careers in Science, Clinical Research, and Medicine.

In her spare time, Dr Gilliam is an Executive Committee member of the Young Presidents Organisation (YPO), a member of CHIEF, AmCham, and the UAE Singapore Business Council.

Dr Gilliam holds a Bachelors degree in Biology, a minor in Chemistry, a Doctor of Pharmacy (PharmD) degree from the University of Michigan, and an MBA in International Business from Rutgers University in Singapore.